PULMONX CORP's ticker is LUNG and the CUSIP is 745848101. A total of 115 filers reported holding PULMONX CORP in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,739,292 | -21.2% | 652,400 | 0.0% | 0.18% | -10.8% |
| Q2 2023 | $8,552,964 | +17.3% | 652,400 | 0.0% | 0.20% | +16.7% |
| Q1 2023 | $7,293,832 | +32.6% | 652,400 | 0.0% | 0.17% | +31.8% |
| Q4 2022 | $5,499,732 | -44.7% | 652,400 | +9.2% | 0.13% | -48.6% |
| Q3 2022 | $9,953,000 | -3.7% | 597,400 | -14.9% | 0.26% | -14.6% |
| Q2 2022 | $10,339,000 | -40.7% | 702,400 | 0.0% | 0.30% | -31.4% |
| Q1 2022 | $17,427,000 | -22.4% | 702,400 | +0.3% | 0.44% | -15.4% |
| Q4 2021 | $22,449,000 | -10.9% | 700,000 | 0.0% | 0.52% | -2.1% |
| Q3 2021 | $25,186,000 | -3.7% | 700,000 | +18.1% | 0.53% | +2.5% |
| Q2 2021 | $26,141,000 | -3.5% | 592,500 | 0.0% | 0.52% | -12.5% |
| Q1 2021 | $27,101,000 | -21.5% | 592,500 | +18.5% | 0.59% | -19.3% |
| Q4 2020 | $34,510,000 | – | 500,000 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XIII Associates, LLC | 994,971 | $43,898,000 | 8.08% |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 93,831 | $4,140,000 | 8.00% |
| Miura Global Management | 570,000 | $25,148,000 | 4.59% |
| Iron Triangle Partners LP | 550,000 | $24,266,000 | 2.50% |
| Beck Bode, LLC | 116,442 | $5,137,000 | 1.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,800,887 | $79,455,000 | 1.41% |
| Affinity Asset Advisors, LLC | 60,000 | $2,647,000 | 0.95% |
| PURA VIDA INVESTMENTS, LLC | 595,231 | $26,262,000 | 0.82% |
| RTW INVESTMENTS, LP | 1,129,600 | $49,838,000 | 0.75% |
| ABG Innovation Capital Partners III GP Ltd | 4,521 | $199,000 | 0.67% |